Unknown

Dataset Information

0

The antiepileptic drug valproic acid and other medium-chain fatty acids acutely reduce phosphoinositide levels independently of inositol in Dictyostelium.


ABSTRACT: Valproic acid (VPA) is the most widely prescribed epilepsy treatment worldwide, but its mechanism of action remains unclear. Our previous work identified a previously unknown effect of VPA in reducing phosphoinositide production in the simple model Dictyostelium followed by the transfer of data to a mammalian synaptic release model. In our current study, we show that the reduction in phosphoinositide [PtdInsP (also known as PIP) and PtdInsP(2) (also known as PIP(2))] production caused by VPA is acute and dose dependent, and that this effect occurs independently of phosphatidylinositol 3-kinase (PI3K) activity, inositol recycling and inositol synthesis. In characterising the structural requirements for this effect, we also identify a family of medium-chain fatty acids that show increased efficacy compared with VPA. Within the group of active compounds is a little-studied group previously associated with seizure control, and analysis of two of these compounds (nonanoic acid and 4-methyloctanoic acid) shows around a threefold enhanced potency compared with VPA for protection in an in vitro acute rat seizure model. Together, our data show that VPA and a newly identified group of medium-chain fatty acids reduce phosphoinositide levels independently of inositol regulation, and suggest the reinvestigation of these compounds as treatments for epilepsy.

SUBMITTER: Chang P 

PROVIDER: S-EPMC3255550 | biostudies-literature | 2012 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

The antiepileptic drug valproic acid and other medium-chain fatty acids acutely reduce phosphoinositide levels independently of inositol in Dictyostelium.

Chang Pishan P   Orabi Benoit B   Deranieh Rania M RM   Dham Manik M   Hoeller Oliver O   Shimshoni Jakob A JA   Yagen Boris B   Bialer Meir M   Greenberg Miriam L ML   Walker Matthew C MC   Williams Robin S B RS  

Disease models & mechanisms 20110829 1


Valproic acid (VPA) is the most widely prescribed epilepsy treatment worldwide, but its mechanism of action remains unclear. Our previous work identified a previously unknown effect of VPA in reducing phosphoinositide production in the simple model Dictyostelium followed by the transfer of data to a mammalian synaptic release model. In our current study, we show that the reduction in phosphoinositide [PtdInsP (also known as PIP) and PtdInsP(2) (also known as PIP(2))] production caused by VPA is  ...[more]

Similar Datasets

| S-EPMC4282506 | biostudies-literature
| S-EPMC3887064 | biostudies-literature
| S-EPMC10394102 | biostudies-literature
| S-EPMC8251728 | biostudies-literature
| S-EPMC8473879 | biostudies-literature
| S-EPMC1533318 | biostudies-literature
| S-EPMC5672042 | biostudies-literature
| S-EPMC11327439 | biostudies-literature
| S-EPMC7726810 | biostudies-literature
| S-EPMC4682151 | biostudies-literature